Cargando…

Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis

BACKGROUND: Postmenopausal osteoporosis (PMOP), the most frequent bone-related disease, is characterized by bone loss and fragile fractures, which is related to low bone density (BMD). This study aimed to illustrate the expression and mechanism of miR-33a-3p in osteoporosis. METHODS: TargetScan and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Changxin, Shen, Jianfei, Zhang, Wei, Wang, Xiaoyu, Xu, Xiaohong, Lu, Xianghui, Xu, Dongbin, Yao, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326950/ https://www.ncbi.nlm.nih.gov/pubmed/37415192 http://dx.doi.org/10.1186/s13018-023-03883-6

Ejemplares similares

Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis
por: Meng, Jia, et al.
Publicado: (2015)

Interleukin-33 serum levels in postmenopausal women with osteoporosis
por: Ginaldi, Lia, et al.
Publicado: (2019)

MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA
por: Yu, Tao, et al.
Publicado: (2020)

MiR-422a as a Potential Cellular MicroRNA Biomarker for Postmenopausal Osteoporosis
por: Cao, Zheng, et al.
Publicado: (2014)

Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis
por: Ding, Haifeng, et al.
Publicado: (2017)

Overexpression of miR125b Promotes Osteoporosis Through miR-125b-TRAF6 Pathway in Postmenopausal Ovariectomized Rats
por: Wang, Gang, et al.
Publicado: (2021)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal Osteoporosis
por: Wang, Yang, et al.
Publicado: (2012)

The Potential Role of Serum IGF-1 and Leptin as Biomarkers: Towards Screening for and Diagnosing Postmenopausal Osteoporosis
por: Zhang, Yili, et al.
Publicado: (2022)

Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis
por: Xu, Jixi, et al.
Publicado: (2022)

Identification of aberrantly expressed long non-coding RNAs in postmenopausal osteoporosis
por: Fei, Qi, et al.
Publicado: (2018)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Synergistic effects of miR-708-5p and miR-708-3p accelerate the progression of osteoporosis
por: Wang, Ruran, et al.
Publicado: (2020)

Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis
por: Lin, Chujiao, et al.
Publicado: (2019)

MiR-210 improves postmenopausal osteoporosis in ovariectomized rats through activating VEGF/Notch signaling pathway
por: Ren, Li-Jue, et al.
Publicado: (2023)

Identification and evaluation of circulating exosomal miRNAs for the diagnosis of postmenopausal osteoporosis
por: Sun, Zhibang, et al.
Publicado: (2023)

In silico analysis of the molecular mechanism of postmenopausal osteoporosis
por: LIU, YANQING, et al.
Publicado: (2015)

Circulating miR-340-5p and miR-506-3p as Two Osteo-miRNAs for Predicting Osteoporosis in a Cohort of Postmenopausal Women
por: Lu, Zifeng, et al.
Publicado: (2023)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway
por: Zhao, Fujiang, et al.
Publicado: (2021)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)

Postmenopausal osteoporosis: Our experience
por: Mehrotra, R. N., et al.
Publicado: (2012)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Yeast Hydrolysate and Postmenopausal Osteoporosis
por: Hong, Yang Hee, et al.
Publicado: (2023)

Exosomal miR-186 derived from BMSCs promote osteogenesis through hippo signaling pathway in postmenopausal osteoporosis
por: Li, Lu, et al.
Publicado: (2021)

Retracted: Circulating miR-340-5p and miR-506-3p as Two Osteo-miRNAs for Predicting Osteoporosis in a Cohort of Postmenopausal Women
por: Environmental and Public Health, Journal of
Publicado: (2023)

Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
por: Urushihara, Hisashi, et al.
Publicado: (2014)

MiR-206 regulates the progression of osteoporosis via targeting HDAC4
por: Lu, Zhiyuan, et al.
Publicado: (2021)

MiR-26a regulates the expression of serum IGF-1 in patients with osteoporosis and its effect on proliferation and apoptosis of mouse chondrocytes
por: Yuan, Fangchang, et al.
Publicado: (2021)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Introduction to the Guidelines on Menopause and Postmenopausal Osteoporosis
por: Meeta, Meeta
Publicado: (2020)

Long-Term Treatment of Postmenopausal Osteoporosis
por: Brown, Jacques P.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9qm2p3bul4tobfhghgpl65arb